An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

Major depressive disorder (MDD) is considered a highly heterogeneous clinical and neurobiological mental disorder. We employed a novel layered treatment design to investigate whether cortical thickness features at baseline differentiated treatment responders from non-responders after 8 and 16 weeks...

Full description

Bibliographic Details
Main Authors:	Jee Su Suh, Luciano Minuzzi, Pradeep Reddy Raamana, Andrew Davis, Geoffrey B. Hall, Jacqueline Harris, Stefanie Hassel, Mojdeh Zamyadi, Stephen R. Arnott, Gésine L. Alders, Roberto B. Sassi, Roumen Milev, Raymond W. Lam, Glenda M. MacQueen, Stephen C. Strother, Sidney H. Kennedy, Benicio N. Frey
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158220300127

Similar Items

Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study
by: Sondos Ayyash, et al.
Published: (2024-06-01)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
by: Pedro L. Ballester, et al.
Published: (2021-01-01)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
by: Jacqueline K. Harris, et al.
Published: (2022-01-01)

A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI
by: Mohammad Ali, et al.
Published: (2022-01-01)

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
by: Giorgia Caspani, et al.
Published: (2021-07-01)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
by: Antoine Yrondi, et al.
Published: (2021-09-01)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
by: Athena E. Theyers, et al.
Published: (2021-02-01)

Volumetric MRI Analysis of a Case of Severe Ventriculomegaly
by: Gésine L. Alders, et al.
Published: (2018-12-01)

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
by: Laura M. Fiori, et al.
Published: (2021-08-01)

Resting state fMRI scanner instabilities revealed by longitudinal phantom scans in a multi-center study
by: Aras Kayvanrad, et al.
Published: (2021-08-01)

Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study
by: Prabhjot Dhami, et al.
Published: (2022-12-01)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
by: John-Jose Nunez, et al.
Published: (2021-01-01)

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
by: Anastasiya Slyepchenko, et al.
Published: (2021-08-01)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
by: Juan Pablo Lopez, et al.
Published: (2017-05-01)

Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder
by: Sabrina K. Syan, et al.
Published: (2018-01-01)

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial: the work of M. Alex Wollmer, et al. (2014)
by: Roumen eMilev
Published: (2015-04-01)

Youth at-risk for serious mental illness: methods of the PROCAN study
by: Jean Addington, et al.
Published: (2018-07-01)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
by: Caroline J. K. Wallace, et al.
Published: (2021-02-01)

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
by: Brown EC, et al.
Published: (2018-12-01)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
by: Rixing Lin, et al.
Published: (2023-07-01)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
by: Victoria S. Marshe, et al.
Published: (2021-02-01)

Where did it all go wrong? Implementation failure - and more - in a field experiment of procedural justice policing
by: MacQueen, S, et al.
Published: (2016)

Enhancing public trust and police legitimacy during road traffic encounters: results from a randomised controlled trial in Scotland
by: MacQueen, S, et al.
Published: (2015)

Add-on quetiapine for bipolar depression: twelve months open label prospective trial
by: Abraham Gaby, et al.
Published: (2006-02-01)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
by: Farhana Islam, et al.
Published: (2022-09-01)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
by: Chinna Meyyappan, Arthi, et al.
Published: (2020-06-01)

The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
by: Nirushi Kuhathasan, et al.
Published: (2021-10-01)

An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample
by: Nirushi Kuhathasan, et al.
Published: (2022-04-01)

From anatomy to function: the role of the somatosensory cortex in emotional regulation
by: Erika Kropf, et al.
Published: (2018-12-01)

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
by: Evan Forth, et al.
Published: (2023-02-01)

Using electronically delivered therapy and brain imaging to understand OCD pathology: A pilot feasibility study
by: Callum Stephenson, et al.
Published: (2023-03-01)

Olfactory Functioning and Depression: A Systematic Review
by: Hannah Taalman, et al.
Published: (2017-09-01)

The effects of probiotics on depressive symptoms in humans: a systematic review
by: Caroline J. K. Wallace, et al.
Published: (2017-02-01)

Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 report
by: Manish Dama, et al.
Published: (2022-07-01)

Some methods for classification and analysis of multivariate observations /
by: 343597 MacQueen, J.

Naïve Justice in the Ancient Greek Novel
by: Bruce D. MacQueen
Published: (2016-12-01)

Catching a (Double-Strand) Break: The Rad51 and Dmc1 Strand Exchange Proteins Can Co-occupy Both Ends of a Meiotic DNA Double-Strand Break.
by: Amy J MacQueen
Published: (2015-12-01)

Towards Utopia or Irreconcilable Tensions? Thoughts on Intellectual Property, Human Rights and Competition Law
by: Hector L MacQueen
Published: (2005-12-01)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
by: Anthony L. Vaccarino, et al.
Published: (2023-06-01)